Page last updated: 2024-10-23

atenolol and Rheumatic Heart Disease

atenolol has been researched along with Rheumatic Heart Disease in 1 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.

Research Excerpts

ExcerptRelevanceReference
"To evaluate efficiency of using ACE inhibitor (capoten) and beta-blocker (atenolol) in diverse mitral and aortic valve defects (MVD and AVD, respectively) of rheumatic etiology complicated by chronic cardiac failure (CCF) of the first and second stages."5.09[Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin]. ( Bagirova, GG; Batalina, MV, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagirova, GG1
Batalina, MV1

Trials

1 trial available for atenolol and Rheumatic Heart Disease

ArticleYear
[Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
    Terapevticheskii arkhiv, 2000, Volume: 72, Issue:9

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agent

2000